Katherine Lord, MD

Locations: Main Hospital
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)
MD - Northwestern University Feinberg School of Medicine, Chicago, IL
Pediatrics, Yale New Haven Children's Hospital, New Haven CT
Pediatric Endocrinology, The Children's Hospital of Philadelphia, Philadelphia, PA
Pediatric Endocrinology – American Board of PediatricsPediatrics – American Board of Pediatrics
Attending Physician
Assistant Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania
Adzick NS, De Leon DD, States LJ, Lord K, Bhatti TR, Becker SA, Stanley CA. Surgical treatment of congenital hyperinsulinism: Results from 500 pancreatectomies in neonates and children. J Pediatr Surg. 2019 Jan;54(1):27-32. doi: 10.1016/j.jpedsurg.2018.10.030. Epub 2018 Oct 5.
Lord K, Radcliffe J, Gallagher P, Adzick NS, Stanley CA, De León DD: High Risk of Diabetes and Neurobehavioral Deficits in Individuals with Surgically Treated Hyperinsulinism J Clin Endocrinol Metab 100(11): 4133-4139, November 2015.
Lord K, Dzata E, Snider KE, Gallagher PR, De León DD. Clinical presentation and management of children with diffuse and focal hyperinsulinism: a review of 223 cases. J Clin Endocrinol Metab. 2013 Sep 20. [Epub ahead of print]
Lord K, De León DD. Monogenic hyperinsulinemic hypoglycemia: current insights into the pathogenesis and management. Int J Pediatr Endocrinol. 2013 Feb 6;2013(1):3.
Stanescu DE, Lord K, Lipman TH. The epidemiology of type 1 diabetes in children. Endocrinol Metab Clin North Am. 2012 Dec;41(4):679-94.
Lord K, De Leon DD: Hyperinsulinism. The 5-Minute Pediatric Consult, 7th Edition 2015.
Lord K and Rossi W.: Acquired Hypothyroidism. Decision Support in Medicine 2014.
Lord K, Stewart N, Langdon D, De León DD. Lanreotide is a Safe and Effective Treatment for Congenital Hyperinsulinism. 10th International Joint Meeting of Pediatric Endocrinology, Washington DC September 2017.
Vajravelu ME, Lord K, Givler S, De Leon DD: Protein-induced Hypoglycemia in KATP Hyperinsulinism is Mediated by the GLP-1 Receptor. Eastern Society of Pediatric Research, Philadelphia PA March 2016